VEDOLIZUMAB | B125476 | TAKEDA PHARMS USA
Regulatory Exclusivities
| Type | Expiry | Status | Source |
|---|---|---|---|
| 12-Year BPCIA | May. 20, 2026 | Expired | Computed |
Purple Book Patents
No listed patents in Purple Book.
Estimated Patent LOE
Based on latest discovered patent 12391760(method of use) · relevance 92/100
Estimate based on AI-discovered patents. No patents are officially listed in the Purple Book for this product.
14 AI-discovered patents, sorted by relevance.
No patent or exclusivity listings for this strength.